Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCAP alkaline phosphatase for severe COVID-19 respiratory failure
NL-OMON54916Phase 2Active, not recruiting
- Sponsor
- Rode Kruis Ziekenhuis
- Start
- Dec 2020
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bovine intestinal alkaline phosphatase in coronavirus disease 2019 (COVID-19), sponsored by Rode Kruis Ziekenhuis. Primary endpoints: Duration of mechanical ventilation and Withholding of mechanical ventilation. Started Dec 2020; status: active, not recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON54916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54916.